Discoidin Domain Receptors in Lung Cancer
Authors:
- 14 August 2016
- book chapter
- Published by Springer Nature
- p. 145-154
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial–mesenchymal transition programme under hypoxiaThe Journal of Pathology, 2014
- Discoidin Domain Receptor 2 Signaling Networks and Therapy in Lung CancerJournal of Thoracic Oncology, 2014
- Ceritinib inALK-Rearranged Non–Small-Cell Lung CancerNew England Journal of Medicine, 2014
- Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transitionMedical Oncology, 2013
- The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasisNature Cell Biology, 2013
- Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patientsMedical Oncology, 2013
- Discoidin domain receptor tyrosine kinases: new players in cancer progressionCancer and Metastasis Reviews, 2012
- Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone MetastasisClinical Cancer Research, 2012
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinomaBritish Journal of Cancer, 2007